Skip to main content
Equibles

Anthea Lee

Analyst

Jefferies

Equibles does not estimate personal net worth.

About Anthea Lee

Anthea Lee is recorded as Analyst at Jefferies. Anthea Lee has spoken on 1 earnings call and 2 other investor events across 3 companies, most recently for Tarsus Pharmaceuticals, Inc. on August 6, 2026. Those appearances were for Tarsus Pharmaceuticals, Inc. (TARS), Adicet Bio, Inc. (ACET) and Pacira BioSciences, Inc. (PCRX). The companies whose calls Anthea Lee spoke on are classified in the Healthcare sector.

Anthea Lee on recent calls

“On the XTEMB guidance, the implied script trajectory looks fairly conservative, even accounting for holidays and seasonality. Is there anything we're missing in terms of script acceleration in the second half outside of seasonality?”
Analyst — Jefferies, Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 ·
“And maybe before we get into Q&A, I would love to just have you give some opening remarks about ADASET for those who are not too familiar with the company and kind of key catalyst to look for in the next 6 to 12 months?”
Analyst — Jefferies, Jefferies Global Healthcare Conference in New York ·
“For those who are unfamiliar with Pacira, perhaps we could start with a quick introduction of the company? What are the key goals for this year? And the outlook.”
Analyst — Jefferies, 2026 Jefferies Global Healthcare Conference ·

Affiliation history

  • Jefferies

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity